March 20, 2013 12:54 PM | 1 min read
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
In a report published Wednesday, Citigroup analyst Deborah L. Weinswig upgraded the rating on Walgreen Company (NYSE: WAG) from Sell to Buy, and raised the price target from $32.00 to $51.00.In the report, Weinswig noted, “We are upgrading WAG to Buy from Sell and raising our target price to $51, up from $32 previously. The distribution agreement and potential equity stake in drug distributor AmerisourceBergen (ABC) should result in EPS accretion of $0.09-$0.28 in F2014, and more importantly, demonstrates how WAG is transforming the pharmaceutical supply chain on a global basis. We believe that innovative partnerships like this one and the 45% stake in Alliance Boots position the company well to benefit from the Affordable Care Act taking effect in 2014. Going forward, we expect WAG to continue to develop innovative solutions that drive top and bottom line growth.”Walgreen Company closed on Tuesday at $44.74.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.